Which way has the stock been trending on Chicago Bears linebacker, Danny Trevathan?
There are two ways to look at the offseason Danny Trevathan had. The easy argument is that his stock is on the rise. After an injury-filled 2019 campaign, there were cases to be made that Trevathan would not be on the Chicago Bears at this time.
Trevathan was a free agent and needed to be re-signed in an offseason where the Bears faced a lot of questions and made a lot of roster turnover. However, Trevathan not only was extended, he saw fair, if not above market value, and got option years that go well beyond his prime NFL seasons.
Considering the contract Trevathan received, the Bears stock on him is up.
Still, it is hard to write a Trevathan post in 2020 without bringing up the hard underlying truth. He has played 16 games just once in his four years with Chicago, and just twice in his NFL career. Injuries have followed him from Denver to Chicago. In Chicago, he has played 8, 12, 16, and 9 games respectively.
For every case to be made that his stock should be up, there is the overarching cloud of, for how long? 2020 will be the first season he plays over the age of 30, and that is often a tipping point for NFL players to see a decline. What does decline look like for a player who has been beaten up over the years?
Still, the fact that the Bears are relying on Trevathan, and have lost most of their depth behind him is an issue for the Chicago Bears. When looking solely at Danny Trevathan, he saw more guaranteed money than expected, and until he does see an injury, he is the unquestioned starter for the next three seasons. His stock goes up.
Offseason Stock Up